Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population.

about

Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population.

Item

http://www.wikidata.org/entity/Q55174959

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Prognostic impact of CD4-posit ...... nHer trial patient population.

@en

Prognostic impact of CD4-posit ...... nHer trial patient population.

@nl

type

Item

label

Prognostic impact of CD4-posit ...... nHer trial patient population.

@en

Prognostic impact of CD4-posit ...... nHer trial patient population.

@nl

prefLabel

Prognostic impact of CD4-posit ...... nHer trial patient population.

@en

Prognostic impact of CD4-posit ...... nHer trial patient population.

@nl

P1476

Prognostic impact of CD4-posit ...... nHer trial patient population.

@en

P2093

Anne-Sophie Heimes

http://www.w3.org/2001/XMLSchema#string

Annette Hasenburg

http://www.w3.org/2001/XMLSchema#string

Antje Lebrecht

http://www.w3.org/2001/XMLSchema#string

Aslihan Gerhold-Ay

http://www.w3.org/2001/XMLSchema#string

Jan G Hengstler

http://www.w3.org/2001/XMLSchema#string

Katrin Almstedt

http://www.w3.org/2001/XMLSchema#string

Konstantine T Kalogeras

http://www.w3.org/2001/XMLSchema#string

Marco J Battista

http://www.w3.org/2001/XMLSchema#string

Marcus Schmidt

http://www.w3.org/2001/XMLSchema#string

Pirkko-Liisa Kellokumpu-Lehtinen

http://www.w3.org/2001/XMLSchema#string

P2860

Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells

B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5

Comprehensive molecular portraits of human breast tumours

A chemokine-driven positive feedback loop organizes lymphoid follicles

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199.

Immunoglobulin kappa C predicts overall survival in node-negative breast cancer.

Tumor antigen-specific T helper cells in cancer immunity and immunotherapy.

Neoantigens in cancer immunotherapy.

Prognostic significance of FOXP3+ tumor-infiltrating lymphocytes in breast cancer depends on estrogen receptor and human epidermal growth factor receptor-2 expression status and concurrent cytotoxic T-cell infiltration.

P2888

s13058-018-0942-x

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13058-018-0942-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Heikki Joensuu

George Fountzilas

P577

2018-02-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1101228998

http://www.w3.org/2001/XMLSchema#string

P698

29482642

http://www.w3.org/2001/XMLSchema#string

P932

5827982

http://www.w3.org/2001/XMLSchema#string